News EU regulators back blood cancer stem cell therapy Molmed's treatment aims to prevent reduce risk of graft-versus-host disease.
Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
News Astellas suspended from UK pharma trade body ABPI takes action after finding firm misled investigation into its conduct.
Cancer Celgene forms R&D consortium with four US cancer centres New initiative attempts to find next generation of cancer therapies.
Views & Analysis Cancer central to ‘Question Time’-style debate Topics, ranging from the seven-days- a-week NHS to Brexit, were on the oncology panel's agenda.
News UK trailing Europe on access to cancer drugs - report UK has some of the lowest uptake of new cancer drugs.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
